Results 141 to 150 of about 89,726 (201)

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial. [PDF]

open access: yesNat Med
Yap TA   +19 more
europepmc   +1 more source

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. [PDF]

open access: yesCancer
Ahmed J   +12 more
europepmc   +1 more source

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. [PDF]

open access: yesMol Cancer Ther
Nakazawa MS   +20 more
europepmc   +1 more source

CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. [PDF]

open access: yesNPJ Breast Cancer
House NC   +19 more
europepmc   +1 more source

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study. [PDF]

open access: yesBr J Cancer
Yap TA   +14 more
europepmc   +1 more source

Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. [PDF]

open access: yesInt J Radiat Oncol Biol Phys
Jacomina LE   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy